| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w12906 |
| 来源ID | Working Paper 12906 |
| Anti-depressants and Suicide | |
| Jens Ludwig; Dave E. Marcotte; Karen Norberg | |
| 发表日期 | 2007-02-16 |
| 出版年 | 2007 |
| 语种 | 英语 |
| 摘要 | Does drug treatment for depression with selective serotonin reuptake inhibitors (SSRIs) increase or decrease the risk of completed suicide? The question is important in part because of recent government warnings that question the safety of SSRIs, one of the most widely prescribed medications in the world. While there are plausible clinical and behavioral arguments that SSRIs could have either positive or negative effects on suicide, randomized clinical trials have not been very informative because of small samples and other problems. In this paper we use data from 26 countries for up to 25 years to estimate the effect of SSRI sales on suicide mortality using just the variation in SSRI sales that can be explained by cross-country variation in the growth of drug sales more generally. We find that an increase in SSRI sales of 1 pill per capita (about a 12 percent increase over 2000 sales levels) is associated with a decline in suicide mortality of around 5 percent. These estimates imply a cost per statistical life far below most other government interventions to improve health outcomes. |
| 主题 | Health, Education, and Welfare ; Health |
| URL | https://www.nber.org/papers/w12906 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/570572 |
| 推荐引用方式 GB/T 7714 | Jens Ludwig,Dave E. Marcotte,Karen Norberg. Anti-depressants and Suicide. 2007. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w12906.pdf（347KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
